Aerospace series. Standardized measurement methods for comfort and living space criteria for aircraft passenger seats

2015 ◽  
Keyword(s):  
Measurement Methods ◽  
Living Space ◽  
Standardized Measurement

scholarly journals Nasal Nitric Oxide in the Upper Airway Inflammatory Diseases

2021 ◽  
Vol 28 (2) ◽  
pp. 81-88
Author(s):  
Jin Hyeok Jeong
Keyword(s):  
Nitric Oxide ◽  
Respiratory Tract ◽  
Inflammatory Diseases ◽  
Upper Airway ◽  
Measurement Methods ◽  
Upper Respiratory Tract ◽  
Nasal Nitric Oxide ◽  
Obstructive Sleep ◽  
Standardized Measurement ◽  
Upper Respiratory

Exhaled nitric oxide (eNO) from the lower respiratory tract is used commonly in diagnosis and treatment monitoring of asthma patients. However, nasal nitric oxide (nNO) has not been widely used in patients with upper airway inflammatory diseases due to its lack of standardized measurement methods. Nasal nitric oxide is produced mainly by the paranasal sinus mucosa and partially by the nasal mucosa and increases with inflammation. Nasal nitric oxide not only locally supports the defensive mechanism of the upper respiratory tract, but also remotely controls pulmonary function by acting as an aerocrine. Nasal NO can be affected by various physiologic and pathologic factors of the upper respiratory tract. This article will review the origin of nNO, its function, various measurement methods, and difference in presentation among upper respiratory tract inflammatory diseases such as allergic rhinitis, upper respiratory tract infection, nasal polyp, rhinosinusitis, primary ciliary dyskinesia, cystic fibrosis, Young’s syndrome, diffuse panbronchiolitis, empty nose syndrome, and obstructive sleep apnea. Future studies should identify the mechanism of action of nNO in various upper respiratory tract inflammatory diseases and obtain highly reproducible normal values of nNO based on a standardized measurement method with a deeper understanding of factors affecting nNO. Then, nNO will be useful for more rapid and simpler diagnosis of various upper respiratory tract diseases and for monitoring their treatment.

Made Just for You: Comparing Idiographic and Standardized Measurement of Distress

2012 ◽  
Author(s):  
Stephanie A. Harold ◽  
Kelly L. Katuls ◽  
Cortney B. Mauer ◽  
Nathanael J. Taylor ◽  
Gregory H. Mumma
Keyword(s):  
Standardized Measurement

Individualized Versus Standardized Measurement of Distress: Is There a Difference?

2012 ◽  
Author(s):  
Kelly L. Katuls ◽  
Cortney B. Mauer ◽  
Stephanie A. Harold ◽  
Gregory H. Mumma
Keyword(s):  
Standardized Measurement

A critical comparison of selected implicit measurement methods.

2018 ◽  
Vol 11 (4) ◽  
pp. 249-266 ◽  
Author(s):  
Judith Znanewitz ◽  
Lisa Braun ◽  
David Hensel ◽  
Claudia Fantapié Altobelli ◽  
Fabian Hattke
Keyword(s):  
Measurement Methods ◽  
Critical Comparison ◽  
Implicit Measurement

Calibration of a Lyophilized Pooled Plasma as Candidate Reference Plasma for Standardization of the Prothrombin Time Ratio

1993 ◽  
Vol 13 (02) ◽  
pp. 96-105 ◽  
Author(s):  
H. Beeser ◽  
U. Becker ◽  
H. J. Kolde ◽  
E. Spanuth ◽  
P. Witt ◽  
...  
Keyword(s):  
Prothrombin Time ◽  
International Study ◽  
International Normalized Ratio ◽  
Measurement Methods ◽  
Factor V ◽  
Diagnostic Instruments ◽  
Plasma Pool ◽  
Normal Plasma ◽  
German Association ◽  
Prothrombin Time Ratio

SummaryThe prothrombin time (PT), obtained from a fresh normal plasma pool (FPP), is the basis both for the establishment of the 100% activity (normal plasma) and for the ratio calculation used in the International Normalized Ratio (INR) according to the recommendations of the ICSH/ICTH (6). Today the PT of lyophilized normal plasma pools are successfully used as reference for the assessment of samples in proficiency studies. However, a lack of comparability is to be recognized. Therefore the Committee of Hematology of the German Association of Diagnostics’ and Diagnostic Instruments’ Manufacturers (VDGH) decided to produce a candidate reference plasma (VDGH Reference Plasma) which was calibrated against fresh normal plasma pools in an international study.The basic calibration was performed by using the same certified BCR thromboplastin (BCT/099) by all participants. The endpoint was determined manually and by using the coagulometer Schnitger-Gross. In additional testings each participant used his own routine thromboplastins and methods. Calculating the ratio [PT VDGH Reference Plasma (sec)/PT fresh normal plasma pool (sec)] the VDGH Reference Plasma showed a deviation from the average fresh normal plasma pool of 1.05 both with the BCT/099 and with all thromboplastins. There were obtained some statistical differences between “plain” and “combined’’ (added factor V and fibrinogen) thromboplastins. No statistical difference was found between the different endpoint measurement methods (manual, mechanical, optical).In spite of these statistical deviations the VDGH Reference Plasma can be used for the standardization of the PT-normal (100%) value with different ratios for plain (1.06) and combined (1.02) thromboplastins. The manufacturers will use this VDGH Reference Plasma for the calibration of their commercially available calibration plasmas, which allows the user of such a material to calculate a calibrated 100% PT value.

Sign in / Sign up

Export Citation Format

Share Document